搜尋結果
US FDA sends warning letter to Cardinal Health for marketing unapproved devices
Reuters· 3 小時前, opens new tab after an inspection of its facility in Illinois found the company was marketing ...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
CNBC· 11 小時前It also said it plans to cut $1.5 billion in costs by 2025, and reinvest the money in drug deve ...
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
The Wall Street Journal· 11 小時前In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys ... ...
EveryONE Medicines: Designing Drugs for Rare Diseases, One at a Time
The Wall Street Journal· 12 小時前Khosla Ventures, GV, Third Rock Ventures back effort to create medicines for individual ...
Gilead posts quarterly loss, revenue rises 5%
Reuters· 2 小時前Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge ...
Alzheimer's drug adoption in US slowed by doctors' skepticism
Reuters· 2 日前Nine months into the U.S. launch of the first drug proven to slow the advance of ...
Witness Claims Matt Gaetz Attended Drug-Fueled Party With Underage Girl In Statement To ...
Forbes· 7 日前... Ethics Committee has obtained a sworn statement from a woman who said she attended a drug- ...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters· 1 小時前Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available ...
Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
The Wall Street Journal· 1 日前Biogen said Wednesday that the number of patients taking the drug, Leqembi, has increased ...
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
CNBC· 1 日前The U.S. Senate has launched an investigation into the high price of Novo Nordisk's popular ...
drug 相關
廣告